Neisseria meningitidisinfection: who, when and where?

Neisseria meningitidis: pathogenesis and immunity

(2015) Mariagrazia Pizza et al.   CURRENT OPINION IN MICROBIOLOGY

Outbreaks of meningococcal B infection and the 4CMenB vaccine: historical and future perspectives

(2015) Jane Whelan et al.   Expert Review of Vaccines

Meningococcal vaccines: Current state and future outlook

(2015) M. Leca et al.   PATHOLOGIE BIOLOGIE

MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine

(2015) Duccio Medini et al.   VACCINE

Application of Multiple-Locus Variable Number Tandem Repeat Analysis to Identify Outbreak-Associated Neisseria meningitides Serogroup C Sequence Type 4821 in China

(2015) Xiaoying Shan et al.   PLoS One

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil

(2014) Márcia de Cantuária Tauil et al.   Brazilian Journal of Infectious Diseases

Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales

(2014) Shamez N. Ladhani et al.   CLINICAL INFECTIOUS DISEASES

Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America

(2014) R. ABAD et al.   EPIDEMIOLOGY AND INFECTION

Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012

(2014) B Törös et al.   Eurosurveillance

Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy

(2014) Vivek Bansal et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Meningococcal carriage: the dilemma of 4CMenB vaccine

(2014) Muhamed-Kheir Taha et al.   LANCET

Epidemiology of invasive meningococcal disease in the Netherlands, 1960–2012: an analysis of national surveillance data

(2014) Merijn W Bijlsma et al.   LANCET INFECTIOUS DISEASES

Genetic Diversity and Levels of Expression of Factor H Binding Protein among Carriage Isolates of Neisseria meningitidis

(2014) Ludovic Lemée et al.   PLoS One

Bexsero® chronicle

(2014) George Vernikos et al.   Pathogens and Global Health

Genome-Based Bacterial Vaccines: Current State and Future Outlook

(2013) Alexandra Schubert-Unkmeir et al.   BIODRUGS

Prolonged University Outbreak of Meningococcal Disease Associated With a Serogroup B Strain Rarely Seen in the United States

(2013) Sema Mandal et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

(2013) Timo Vesikari et al.   LANCET

Single Nucleotide Polymorphisms in Pathogen Recognition Receptor Genes Are Associated with Susceptibility to Meningococcal Meningitis in a Pediatric Cohort

(2013) Gijs Th J. van Well et al.   PLoS One

Molecular Characterization of Invasive Neisseria meningitidis Strains Isolated in Chile during 2010–2011

(2013) Gisselle N. Barra et al.   PLoS One

A Decade of Invasive Meningococcal Disease Surveillance in Poland

(2013) Anna Skoczyńska et al.   PLoS One

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X

(2013) F. Micoli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine

(2013) Ouli Xie et al.   VACCINE

Distribution of invasive meningococcal B disease in Italian pediatric population: Implications for vaccination timing

(2013) Chiara Azzari et al.   VACCINE

An epidemiological review of changes in meningococcal biology during the last 100 years

(2013) Anne Abio et al.   Pathogens and Global Health

Toll-like receptor 9polymorphisms are associated with severity variables in a cohort of meningococcal meningitis survivors

(2012) Marieke S Sanders et al.   BMC INFECTIOUS DISEASES

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study

(2012) María Elena Santolaya et al.   LANCET

Polymorphisms in Toll-Like Receptors 2, 4, and 9 Are Highly Associated with Hearing Loss in Survivors of Bacterial Meningitis

(2012) Gijs Th J. van Well et al.   PLoS One

Toward a Meningitis-Free World

(2012) S. Black et al.   Science Translational Medicine

Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy

(2012) Angela Bechini et al.   VACCINE

Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines

(2012) Shamez N. Ladhani et al.   VACCINE

The challenge of post-implementation surveillance for novel meningococcal vaccines

(2012) Matthew D. Snape et al.   VACCINE

The changing epidemiology of meningococcal disease in North America 1945–2010

(2012) Carmen Baccarini et al.   Human Vaccines & Immunotherapeutics

Meningococcal disease in Asia: an under-recognized public health burden

(2011) A. VYSE et al.   EPIDEMIOLOGY AND INFECTION

Meningococcal disease: The advances and challenges of meningococcal disease prevention

(2011) Ram Yogev et al.   Human vaccines & immunotherapeutics

Genotypic and Phenotypic Characterization of Carriage and Invasive Disease Isolates of Neisseria meningitidis in Finland

(2011) U. Jounio et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mechanisms of meningococcal colonisation

(2011) Kaushali Trivedi et al.   TRENDS IN MICROBIOLOGY

The changing and dynamic epidemiology of meningococcal disease

(2011) Scott A. Halperin et al.   VACCINE

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease

(2010) Sonia Davila et al.   NATURE GENETICS

Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines

(2010) J. Donnelly et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Serogroup C meningococci in Italy in the era of conjugate menC vaccination

(2009) Paola Stefanelli et al.   BMC INFECTIOUS DISEASES

Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: A prospective, observational study of children and adolescents with proven pneumococcal infection

(2009) Massimo Resti et al.   CLINICAL THERAPEUTICS

Vaccinology in the genome era

(2009) C. Daniela Rinaudo et al.   JOURNAL OF CLINICAL INVESTIGATION

Invasive meningococcal disease in Malta: an epidemiological overview, 1994-2007

(2009) M. Muscat et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development

(2009) Helena Lo et al.   LANCET INFECTIOUS DISEASES

Análisis de las características epidemiológicas y de los factores pronósticos en la enfermedad meningocócica invasiva probable o confirmada en una cohorte de adolescentes y adultos durante un brote epidémico

(2009) J. Aguilar-García et al.   REVISTA CLINICA ESPANOLA

Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)

(2009) Ana I. Martínez et al.   VACCINE

Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis

(2009) David S. Stephens   VACCINE

Global epidemiology of meningococcal disease

(2009) Lee H. Harrison et al.   VACCINE

A toll-like receptor 4 variant is associated with fatal outcome in children with invasive meningococcal disease

(2008) Joerg Faber et al.   ACTA PAEDIATRICA

Genetic characteristics of serogroup A meningococci circulating in China, 1956–2005

(2008) X. Zhang et al.   CLINICAL MICROBIOLOGY AND INFECTION

NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens

(2008) Vinita S. Chauhan et al.   GLIA

Important Role for Toll-Like Receptor 9 in Host Defense against Meningococcal Sepsis

(2008) H. Sjolinder et al.   INFECTION AND IMMUNITY

Meningococcemia without Meningitis in Japan

(2008) Tetsuya Horino et al.   INTERNAL MEDICINE

PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine

(2008) C. Sorhouet Pereira et al.   JOURNAL OF MEDICAL MICROBIOLOGY

MeNZB™ vaccine and epidemic control: When do you stop vaccinating?

(2008) Belinda J. Loring et al.   VACCINE